Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 5/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.51 |
| ▸ | MAPT | P10636 | 3/20 | 0.51 |
| ▸ | POLB | P06746 | 3/20 | 0.51 |
| ▸ | HTT | P42858 | 2/20 | 0.51 |
| ▸ | USP2 | O75604 | 2/20 | 0.51 |
| ▸ | RGS12 | O14924 | 1/20 | 0.51 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.51 |
| ▸ | ATM | Q13315 | 1/20 | 0.51 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.51 |
| ▸ | TLR9 | Q9NR96 | 1/20 | 0.51 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.51 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.51 |
| ▸ | HDAC1 | Q13547 | 7/20 | 0.46 |
| ▸ | HDAC6 | Q9UBN7 | 7/20 | 0.46 |
| ▸ | HDAC3 | O15379 | 6/20 | 0.46 |
| ▸ | HDAC11 | Q96DB2 | 6/20 | 0.46 |
| ▸ | HDAC8 | Q9BY41 | 6/20 | 0.46 |
| ▸ | NCOR2 | Q9Y618 | 5/20 | 0.46 |
| ▸ | HDAC7 | Q8WUI4 | 3/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1760809 | 0.98 | MEN1 (0.51) | MEN1KMT2AMAPTPOLBHTT | |
| SCHEMBL1760751 | 0.94 | MEN1 (0.55) | MEN1KMT2AMAPTPOLBHTT | |
| SCHEMBL1760808 | 0.94 | MEN1 (0.52) | MEN1KMT2AMAPTPOLBHTT | |
| SCHEMBL1760787 | 0.93 | MEN1 (0.55) | MEN1KMT2AMAPTPOLBHTT | |
| SCHEMBL1760760 | 0.93 | MEN1 (0.55) | MEN1KMT2AMAPTPOLBHTT | |
| SCHEMBL1760767 | 0.89 | KMT2A (0.54) | MEN1KMT2AMAPTPOLBHTT | |
| SCHEMBL1760764 | 0.89 | KMT2A (0.54) | MEN1KMT2AMAPTPOLBHTT | |
| SCHEMBL12377349 | 0.87 | MEN1 (0.63) | MEN1KMT2AMAPTPOLBHTT | |
| SCHEMBL1760746 | 0.85 | KMT2A (0.55) | MEN1KMT2AMAPTPOLBHTT | |
| SCHEMBL14397348 | 0.85 | KMT2A (0.55) | MEN1KMT2AMAPTPOLBHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7988741-B2 | Specific naphthalmide-type dyes, dye composition comprising at least one such dye, process using same and uses | L'OREAL S.A. (FR) | 2011-08-02 | — | — | US | claimed |
| US-20110113572-A1 | SPECIFIC NAPHTHALMIDE-TYPE DYES, DYE COMPOSITION COMPRISING AT LEAST ONE SUCH DYE, PROCESS USING SAME AND USES | L' OREAL S.A. (FR) | 2011-05-19 | — | — | US | claimed |
| US-7988741-B2 | Specific naphthalmide-type dyes, dye composition comprising at least one such dye, process using same and uses | L'OREAL S.A. (FR) | 2011-08-02 | — | — | US | disclosed |
| US-7988741-B2 | Specific naphthalmide-type dyes, dye composition comprising at least one such dye, process using same and uses | L'OREAL S.A. (FR) | 2011-08-02 | — | — | US | disclosed |
| US-20110113572-A1 | SPECIFIC NAPHTHALMIDE-TYPE DYES, DYE COMPOSITION COMPRISING AT LEAST ONE SUCH DYE, PROCESS USING SAME AND USES | L' OREAL S.A. (FR) | 2011-05-19 | — | — | US | disclosed |
| US-20110113572-A1 | SPECIFIC NAPHTHALMIDE-TYPE DYES, DYE COMPOSITION COMPRISING AT LEAST ONE SUCH DYE, PROCESS USING SAME AND USES | L' OREAL S.A. (FR) | 2011-05-19 | — | — | US | disclosed |
| EP-1963436-A2 | SPECIFIC DYES OF NAPHTHALIMIDE TYPE, DYEING COMPOSITION COMPRISING AT LEAST ONE SUCH DYE, METHOD OF IMPLEMENTATION AND USES | L'Oréal (FR) | 2008-09-03 | — | — | EP | disclosed |
| WO-2007110530-A2 | SPECIFIC DYES OF NAPHTHALIMIDE TYPE, DYEING COMPOSITION COMPRISING AT LEAST ONE SUCH DYE, METHOD OF IMPLEMENTATION AND USES | L'OREAL (FR) | 2007-10-04 | — | — | WO | disclosed |
| WO-2007110530-A2 | SPECIFIC DYES OF NAPHTHALIMIDE TYPE, DYEING COMPOSITION COMPRISING AT LEAST ONE SUCH DYE, METHOD OF IMPLEMENTATION AND USES | L'OREAL (FR) | 2007-10-04 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110113572-A1 | SPECIFIC NAPHTHALMIDE-TYPE DYES, DYE COMPOSITION COMPRISING AT LEAST ONE SUCH DYE, PROCESS USING SAME AND USES | KRT18, NEFM, NDC1 | MEN1 2652/4885KMT2A 2748/4885MAPT 461/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.